Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

Viking Therapeutics (VKTX) EPS (Basic): 2014-2024

Historic EPS (Basic) for Viking Therapeutics (VKTX) over the last 11 years, with Dec 2024 value amounting to -$1.01.

  • Viking Therapeutics' EPS (Basic) fell 268.18% to -$0.81 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.12, marking a year-over-year decrease of 127.96%. This contributed to the annual value of -$1.01 for FY2024, which is 10.99% down from last year.
  • Per Viking Therapeutics' latest filing, its EPS (Basic) stood at -$1.01 for FY2024, which was down 10.99% from -$0.91 recorded in FY2023.
  • In the past 5 years, Viking Therapeutics' EPS (Basic) registered a high of -$0.54 during FY2020, and its lowest value of -$1.01 during FY2024.
  • Its 3-year average for EPS (Basic) is -$0.94, with a median of -$0.91 in 2023.
  • Data for Viking Therapeutics' EPS (Basic) shows a maximum YoY plummeted of 50.00% (in 2020) over the last 5 years.
  • Viking Therapeutics' EPS (Basic) (Yearly) stood at -$0.54 in 2020, then plummeted by 31.48% to -$0.71 in 2021, then decreased by 26.76% to -$0.90 in 2022, then dropped by 1.11% to -$0.91 in 2023, then fell by 10.99% to -$1.01 in 2024.